Applicant, as named in the Orange Book

Abbvie Endocrine Inc

Next listed expiry: Lupron Depot on 5 Feb 2031. 2 products with live protection, 3 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Lupron Depot · 3 strengths leuprolide acetate	leuprolide acetate	020517	5 Feb 2031	patent
Lupron Depot-Ped Kit · 6 strengths leuprolide acetate	leuprolide acetate	020263	5 Feb 2031	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (3)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Lupron Depot leuprolide acetate	leuprolide acetate	019732	open now	no listed protection
Lupron Depot leuprolide acetate	leuprolide acetate	020011	open now	no listed protection
Lupron Depot leuprolide acetate	leuprolide acetate	020708	open now	no listed protection